Angiotensin II receptors and drug discovery in cardiovascular disease
- 13 December 2010
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 16 (1-2), 22-34
- https://doi.org/10.1016/j.drudis.2010.11.016
Abstract
No abstract availableKeywords
This publication has 143 references indexed in Scilit:
- Angiotensin-(1–12) requires angiotensin converting enzyme and AT1 receptors for cardiovascular actions within the solitary tract nucleusAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- The ANG-(1–7)/ACE2/mas axis in the regulation of nephron functionAmerican Journal of Physiology-Renal Physiology, 2010
- Angiotensin-converting enzymes and drug discovery in cardiovascular diseasesDrug Discovery Today, 2010
- Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Intrauterine Growth Restriction: Fetal Programming of Hypertension and Kidney DiseaseAdvances in Chronic Kidney Disease, 2008
- Metabolic programming in pregnancy: studies in animal modelsGenes & Nutrition, 2007
- The developmental origins of adult disease (Barker) hypothesisAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2006
- Transcription of the Rat Angiotensin II Type 2 Receptor GeneBiochemical and Biophysical Research Communications, 1996
- Gene Transcription of Angiotensin II Type 2 Receptor Is Repressed by Growth Factors and Glucocorticoids in PC12 CellsBiochemical and Biophysical Research Communications, 1995
- Glucocorticoid Induction of Rat Angiotensin II Type 1A Receptor Gene PromoterBiochemical and Biophysical Research Communications, 1994